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Background: There is a need to elucidate what affects the implantation and early pregnancy 
course in pregnancies conceived with assisted reproductive technology (ART) so that   pregnancy 
rates and outcomes can be improved. Our aim was to determine the role of maternal   Helicobacter 
pylori infection.
Material and methods: We did a prospective study of 187 infertile couples undergoing 
intracytoplasmic sperm injection (ICSI) and segregated those according to underlying infertility 
etiology. We assessed the status of H. pylori IgG antibodies and anti-CagA IgG antibodies by 
ELISA assay. All pregnancies were followed for early pregnancy loss (EPL, first 12 weeks).
Results: The likelihood of H. pylori infection increased with age (1.01, 95% confidence interval 
[CI]: 1.0–1.13; P = 0.040) but there was no association with EPL. Women infected with CagA-
positive strains were more likely to have EPL (19.39, 95% CI: 1.8–208.4; P = 0.014). Women 
with tubal factor or ovulatory disorder infertility were more likely to abort early (12.95, 95% 
CI: 1.28–131.11; P = 0.030, 10.84, 95% CI: 1.47–80.03; P = 0.020, respectively). There was 
no association between EPL and age, number of embryos formed or transferred, or number of 
oocytes retrieved.
Conclusion: Our findings suggest that infection with CagA-positive H. pylori strains is linked 
to an increase in women’s potential to abort early (possibly through increased release of inflam-
matory cytokines). In addition, tubal factor and ovulatory disorder infertility are linked to EPL 
after ICSI due to unknown mechanisms. Proposals to eradicate H. pylori infection prior to ICSI 
could lead to a decrease in EPL after ART.
Keywords: Helicobacter pylori, early pregnancy loss, early abortion, infertility, intracytoplas-
mic sperm injection, CagA
Introduction
Infertility is defined as the failure to conceive after 1 year of regular, unprotected inter-
course.1 This condition affects up to one in seven couples in industrialized countries,2 
and it is one of the most prevalent chronic health disorders involving young adults.3
Several methods have been introduced to help infertile couples conceive, including 
intracytoplasmic sperm injection (ICSI). ICSI was introduced in 1992 as a solution for 
male infertility4 and in 2007, ICSI represented 48% of all in vitro fertilization treatments 
in the UK.5 In this procedure, a single sperm is injected directly into the oocyte cytoplasm, 
and it represents a very effective therapy option in men with very low sperm counts. The 
clinical pregnancy rates after ICSI have been reported to reach 39.2% per embryo transfer,6 
and the overall success of ICSI seems dependent on factors such as sperm retrieval 
method,7 maternal age, and whether the infertility is primary or secondary.8 In addition, 
miscarriage significantly reduces the initial success of assisted reproduction treatment.9
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Early pregnancy loss (EPL) after ICSI has been linked 
to obesity and increased maternal age.10 However, additional 
unknown barriers affect the efficiency of ICSI treatment and 
require further research.
Helicobacter pylori infection affects more than half of 
the world’s population,11 and is most commonly associated 
with chronic gastritis, which subsequently increases the risk 
of many serious complications, including gastric cancer.12 
Additionally, there are limited reports indicating potential 
correlation between infertility and H. pylori infection.13,14 
It has been shown in mice that H. pylori infected mice show 
a decrease in implantation rates, and their offspring are of low 
birth weight.15 In infertile human males, H. pylori infection 
was shown to be associated with low sperm quality compared 
to uninfected patients.14
The pathogenicity of an H. pylori isolate depends on 
strain-specific factors.16 The cag pathogenicity island, for 
which cytotoxin-associated gene A (CagA) is the marker, 
has been associated with both duodenal ulcer and gastric 
cancer,17 and infection with CagA-positive strain is generally 
associated with a higher level of inflammatory mediators 
compared to CagA-negative strains.
In CagA-positive male patients, a significant reduc-
tion in sperm motility was observed along with increased 
  apoptosis and necrosis14 but no studies describing potential 
role of maternal H. pylori infection in pregnancy course exist. 
Should the detrimental effect of H. pylori on pregnancies 
conceived by assisted reproductive technology (ART) be 
confirmed, appropriate treatment of H. pylori infection prior 
to ART treatment could improve the treatment success.
Our aim was to investigate the link between maternal 
H. pylori infection and implantation rates and EPL in patients 
undergoing ICSI.
Methods
Participants
Between January 2009 and September 2009, we did a pro-
spective cohort study, to which we consecutively enrolled 
women undergoing ICSI at the Centre for Treatment and 
Research in Infertility of Shahid Mottahari hospital in Urmia, 
Iran. The Centre for Treatment and Research in Infertility 
is the only infertility clinic in the West Azarbaijan province 
of Iran, and all infertile patients in the area are referred to 
this centre. All patients were of similar age and lived in the 
same region. Patients’ infertility was defined as a failure to 
conceive after 1 year of unprotected intercourse.
The study was approved by the university Institutional 
Review Board and Ethics Committee. Informed written 
consent was obtained from all participants in the   presence 
of a witness. The study is summarized in a flowchart 
(Figure 1).
Procedures
We treated women undergoing ICSI with standard clinical 
and laboratory protocols.
Briefly, couples initially underwent routine fertility 
work-up consisting of semen analysis, sonohysterography 
and female hormone testing (luteinizing hormone [LH], folli-
cle stimulating hormone [FSH], prolactin, thyroid stimulating 
hormone [TSH], estradiol). Hormone levels were evaluated 
on the third day of the patient’s menstrual cycle.
Ovarian stimulation with gonadotropin-releasing hor-
mone (GnRH) agonist buserelin acetate (Suprefact®; Hoechst 
AG, Frankfurt, Germany), at a dose between 0.3–0.5 mg/SC, 
was started during the midluteal phase in a long protocol 
manner starting on the 21st day of the previous cycle. Then 
a daily injection of human menopausal gonadotropin (HMG) 
(Menogon®, Ferring, Kiel, Germany) was administered and 
the GnRH dose was lowered to 50% upon the administra-
tion of HMG.
The dose of HMG was increased in accordance with 
individual patient’s response and in accordance with a 
series of transvaginal sonographic observations until at 
least two follicles reached a mean diameter of 18 mm. Then 
5000–10000 IU of HCG (Pregnyl®, Merck/Schering-Plough 
Pharmaceuticals Inc, Sumneytown Pike, North Wales) was 
injected intramuscularly and after 34–36 hours, transvaginal 
ultrasound-guided oocyte retrieval was performed.
Spermatocyte preparation
Ejaculates were obtained immediately before or shortly after 
oocyte retrieval.
In cases of obstructive and non-obstructive azoospermia, 
spermatozoa were obtained by microsurgical epididymal 
sperm aspiration (MESA) or testicular sperm extraction 
(TESE), respectively.
Intracytoplasmic sperm injection
Oocytes were microscopically examined for the presence 
of cytoplasmic abnormalities before sperm injection. ICSI 
treatment was performed 5–8 hours after oocyte retrieval.
The technique of ICSI has previously been described in 
detail.18 In brief, at a magnification of ×400, a single sper-
matozoon was immobilized by mechanical damage to its tail. 
Prior to ICSI, the oocyte was held in place with a holding 
pipette (Eppendorf, Hamburg, Germany) at 9 O’clock. The 
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first polar body was located on the 6 O’clock position. After 
penetrating both the zona pellucida and the oolemma, a small 
volume of the oocyte cytoplasm was aspirated to activate the 
egg. The previously immobilized spermatozoon was placed 
near the horizontal axis. Withdrawal was conducted care-
fully to prevent leakage from the oocyte. One embryologist 
performed all ICSI treatments.
After sperm injection, fertilized oocytes were placed in 
individual culture media dishes in an incubator (Labotech, 
  Berlin, Germany), using an environment with 5% CO2, at 
37°C, in a filtered humidified atmosphere. Normal fertiliza-
tion and survival was assessed at 14–18 hours after sperm 
injection.
If at least one embryo of grade A to C was identified 
48–72 hours after ovarian puncture, it was transferred into 
the uterine cavity. 
Embryo grading
Prior to the transfer procedure (approximately 48 hours 
post-insemination), the embryo development and mor-
phology were determined, and the embryos for transfer 
were selected. Each embryo was assessed according to the 
blastomere   number, the degree of fragmentation, the uni-
formity of blastomeres, and the presence of multinucleated 
blastomeres.
Intracytoplasmic sperm injection (ICSI)
Grade A were embryos with equally sized blastomeres, 
cells without granulation, and with regular zona pellucida. 
Grade B were those with equally divided cells and 10% 
granulation. Grade C were those with unequal cells and 20% 
granulation. Embryos with unequally-sized blastomeres or 
20% fragments, unequally-sized blastomeres or 50% 
fragments, and 80% fragmentation or with no detectable 
blastomeres were not transferred.
Patient follow-up after embryo transfer
Patients received 30 mg of intramuscular progesterone 
twice-a-day (progesterone 50 mg/IM, Aburaihan Co, Tehran, 
Iran) after embryo transfer, to reinforce the luteal phase. 
Serum human chorionic gonadotropin (hCG) was measured 
14–15 days post-transfer.
In those with a positive hCG response, we measured hCG 
again after 2 days. Patients were followed for 12 weeks sono-
graphically to determine early abortion (week 4, 6, 9, 12).
Determination of antibodies  
against H. pylori
Complete blood count (CBC) is an integral part of the routine 
check-up prior to surgery for all patients undergoing ICSI. 
Upon drawing blood for CBC, an additional 2 mL of patients’ 
A total of 187 women were involved
in the study
37 were excluded due to exclusion
criteria’s
150 were eligible
58 were positive for H.pylori
IgG
39 were CagA negative
35 didn’t become
pregnant (60%)
16 CagA negative
(69.9%)
7 CagA positive
(30.4%)
23 became
pregnant (40%)
19 were CagA positive 65 not pregnant
(70%)
23 (65.7%)
CagA−ve
1 (6.25%)
aborted
15 (93.75%)
no abortion
6 women aborted
(85.7%)
1 women with no
abortion (14.3%)
12 (34.3%)
CagA+ve
27 (29.4) became pregnant
6 (22.2%)
aborted
21 (77.8%)
not aborted
92 were Negative for H.pylori
IgG
Figure 1 Flowchart summarizing the study.
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blood were taken for H. pylori IgG assessment. The blood 
was centrifuged and the serum was kept at −20°C until the 
day of examination.
The status of H. pylori IgG was determined serologically 
using enzyme-linked immunosorbent assay (ELISA) (Serum 
Anti-H. pylori IgG, H. pylori CagA-Ig, Diaplus Inc, North 
York, ON). Titer levels  20 for IgG and  5 for CagA were 
considered positive. If a patient was positive for anti-H.pylori 
IgG, she also underwent further assessment to determine the 
anti-CagA IgG status.
Statistical analysis
Statistical analysis was performed using SPSS (v 16; IBM, 
Chicago, IL) and R package (http://www.r-project.org). 
We used a logistic regression to predict EPL from age, 
H. pylori status, CagA positivity, underlying infertility 
etiology, number of oocytes obtained, number of embryos 
formed, and number of transferred embryos. A P-value 
less than or equal to 0.05 was considered statistically 
significant.
Results
We enrolled 187 and assessed 150 women undergoing ICSI 
for pregnancy rates, H. pylori seropositivity, and EPL. The 
mean age of participating women was 30.6 years (SD 5.8). 
The mean age of women who conceived after ICSI and of 
women who were unable to conceive after ICSI was signifi-
cantly different (P , 0.0001, unpaired t-test).
Seventeen couples (11%) had secondary infertility 
and 133 (89%) primary infertility. The primary diagno-
sis of infertility was male factors: oligospermia (sperm 
count ,5 million); asthenospermia (forward sperm motil-
ity , 5%); teratospermia (normal sperm morphology , 4%); 
obstructive azoospermia and non-obstructive azoospermia; 
retrograde ejaculation; and immunologic factors in 81 (54%) 
couples, followed by tubal factor (laparoscopically diagnosed 
bilateral tubal obstruction) in 11 (7%); ovulation disorders 
(patients not responding to ovulation stimulation, intrauterine 
insemination (IUI), and with high FSH levels) in 17 (11%); 
and idiopathic infertility in 41 (27%) (Figure 2). In women 
receiving embryos, 47 (31%) had one embryo transferred, 
40 (27%) had two embryos transferred, 48 (32%) had three 
transferred, eight (5.3%) had four transferred and seven 
(4.6%) had five or more transferred.
We excluded from the study and final analysis (Table 1) 
women with unilateral or bilateral hydrosalpinx (n = 1), 
ovarian cyst formation following the GnRH administration 
diagnosed by TVS on the 2nd day of the menstrual cycle 
(n = 2), history of pregnancy loss (n = 2), ectopic pregnancy 
following ICSI (n = 4), endometriosis (n = 3), patients who 
in the previous 3 months took medications that might lead to 
false negative results (eg, tetracycline and omeprazole, n = 4). 
We also excluded patients with no follicles or less than two 
follicles formed after ovarian stimulation (n = 3), and with 
one or no oocyte obtained at follicle puncture (n = 5).
Fifty-eight patients (39%) were positive for IgG antibod-
ies against H. pylori, while 92 patients (61%) were negative. 
Nineteen patients (13%) with IgG against H. pylori were 
also positive for CagA. Using a linear model, we noted a 
significant association between IgG positivity and maternal 
age (1.01, 95% confidence interval [CI]: 1.0–1.13; P = 0.040; 
but not CagA positivity; P = 0.41).
We noted a significant association between CagA 
  positivity and EPL (19.39, 95% CI: 1.8–208.4; P = 0.014).
There was a significant association between EPL and 
underlying infertility etiology (12.95, 95% CI: 1.28–131.11, 
P = 0.03 for tubal factor, 10.84, 95% CI: 1.47–80.03, P = 0.02 
for ovulation disorder).
Out of 58 patients with H. pylori infection, 23 became 
pregnant after ICSI, and among 92 H. pylori negative 
patients, 27 became pregnant (1.58, 95% CI: 0.79–3.16; 
P = 0.19). This indicates that H. pylori infection does not 
affect pregnancy rates after ICSI.
Among 23 H. pylori positive pregnant women, seven 
(30%) were also positive for CagA strains, and among 
35 H. pylori positive women that did not conceive after ICSI, 
12 (34%) were also positive for CagA. There was no signifi-
cant link between CagA infection and pregnancy following 
ICSI (0.83, 95% CI: 0.26–2.56; P = 0.76).
0
MF
UA
TF
OD
51 01 5
Number of patients
20 25
Pregnant
EPL
CagA+
Figure 2 Pregnancy rates, EPL, and infection with CagA-positive strains distributed 
across groups with different infertility etiology.
Abbreviations: MF, male factor; UA, unknown etiology; TF, tubal factor; OD, 
ovulatory dysfunction.
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Discussion
Our findings indicate that infection with CagA strains 
of H. pylori is associated with EPL following ICSI. The 
likelihood of EPL also increases with tubal factor and 
ovulatory disorder as the underlying infertility etiology. 
The pregnancy rates were not affected by H. pylori infec-
tion nor CagA positivity, but were affected by maternal 
age (P = 0.0001).
We also observed a statistically significant link between 
the increase in age and H. pylori infection in infertile women 
(P = 0.040), which has not been reported previously.
This finding may indeed reflect the trend described 
previously in children, general population couples, and 
Welsh men,19 which suggests that the prevalence of H. 
pylori infection generally increases with age.20 Since age 
has been reported to contribute to the increase of EPL after 
ICSI, we may hypothesize that undetected CagA-positive H. 
pylori infection among subjects in those studies may have 
been an additional factor underlying this observed trend. 
We observed no association between EPL and maternal 
age (P = 0.15).
Although ICSI is an efficient solution for many infertile 
couples, it is generally accompanied by high rates of EPL, 
ranging from 12% to 48%.21 EPL not only significantly reduces 
the efficiency of the treatment, it also increases the psychologi-
cal burden on patients undergoing the procedure.21
Various factors have been comprehensively reported to 
contribute to EPL in ICSI, including overweight,22   ovarian 
stimulation with GnRH antagonists,23 maternal age,9 
  smoking, and the transfer of poor quality embryos.21 Based 
on our data, we postulate that other causes of EPL following 
ICSI include infection with H. pylori CagA-positive strains 
and tubal factor and ovulation disorder.
Recently the evidence indicating the causative role 
of H. pylori infection in pregnancy failure has been 
rapidly   accumulating: In males, it has been shown that 
H. pylori infection may affect semen quality in men with 
idiopathic infertility,14 with two hypotheses explaining this 
finding: inflammatory reaction to infection, and the immune 
reaction between H. pylori and the sperm antigen.
It has been demonstrated that CagA-positive strains of 
H. pylori can cause injury to different organ systems includ-
ing male and female reproductive organs through the release 
of different inflammatory mediators, such as IL-8, IL-1β, and 
TNF-α.24 TNF-α is multifunctional cytokine with a regulatory   
role in many fundamental processes, such as immunologic 
response, angiogenesis, or apoptosis, and is formed both 
by the placenta and the uterus. It is also associated with 
apoptosis in different cell lines including the sperm, and 
has a negative effect on sperm motility. Increase in TNF-α 
production can lead to pregnancy failure,25 and TNF-α levels 
are reportedly high in patients infected with CagA-positive 
H. pylori strains.14,26 It may be assumed that CagA-positive 
strains of H. pylori could increase the rates of EPL through 
TNF-α-related mechanisms.
Our study has detected a significant correlation between 
different infertility causes and EPL, specifically ovarian 
dysfunction and tubal factor. This is the first study to observe 
such a trend.
Polycystic ovary syndrome (PCOS) has been linked to 
an increased risk of miscarriage,27 but exact mechanisms 
related to this observance remain enigmatic. Various factors 
have been implicated, including dysfunction of the Dicer,29 
angiotensin-converting enzyme and plasminogen activator 
inhibitor-1 gene polymorphisms,30 and interestingly, PCOS 
has been linked to H. pylori infection.31 Although our data do 
not provide sufficient insight into the exact mechanism under-
pinning EPL in women with ovarian dysfunction infertility, 
they demonstrate with high significance that this infertility 
etiology is an independent risk factor for EPL.
Tubal infertility and EPL has been previously linked to 
total antioxidant capacity,27 otherwise there is no evidence 
Table 1 Early pregnancy loss related to maternal age, H. pylori infection, CagA positivity, underlying infertility etiology (IA), number of 
oocytes retrieved (OR), number of embryos formed (EF), and number of embryos transferred (ET)
Odds ratio Lower CI Upper CI P value Number
Age 0 0.79 1.04 0.15 150
IgG positivity 0.47 0.05 4.52 0.52 58
CagA positivity 19.39 1.8 208.4 0.01* 19
Unknown IA 4.68 0.73 29.84 0.1 41
IA:tubal factor 12.95 1.28 131.11 0.03* 11
IA:ovulatory disorder 10.84 1.47 80.03 0.02* 17
OR 0.89 0.66 1.2 0.44 Unknown
EF 1.11 0.77 1.61 0.57 Unknown
ET 1.17 0.68 2.03 0.57 343
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linking this infertility etiology to EPL, nor there is an 
evidence linking tubal infertility with H. pylori.
The CagA seropositivity in Iran has been reported to reach 
72.8%.28 Infection with H. pylori CagA-positive strains has 
been shown to cause a severe inflammatory response and 
significant neutrophil infiltration in the gastric mucosa.29 
Our finding of a statistically significant relationship between 
CagA-positive strains of H. pylori and EPL might be explica-
ble on the basis of general inflammatory reaction to infection. 
Concentrations of IL-1β, IL-8, and TNF-α were all signifi-
cantly higher in H. pylori-positive gastric mucosa samples.30  
These cytokines may cause systemic inflammation that could 
affect the integrity of the fetoplacental unit and threaten the 
welfare of the foetus.31 It was shown that poor oral hygiene 
is associated with a history of miscarriage,31 possibly due to 
systemic inflammatory response to oral bacterial infection. It 
may be assumed that a parallel mechanism underpins the EPL 
in women infected with CagA-positive H. pylori strains.
The limitations of our study include the determination 
of H. pylori infection with only one method; although the 
ELISA kit employed in this study has sensitivity and specific-
ity of about 85%. Additionally, the number of women with 
CagA-positive strain H. pylori infection was relatively low. 
We also included no paternal variable in the study.
Based on our results, we hypothesize that CagA-positive 
H. pylori strains play a significant role in EPL after ICSI. 
Since ICSI is generally a very straining, time-consuming, 
and costly procedure, and the eradication of H. pylori is 
relatively cheap and easy to achieve, we propose that CagA 
status should be determined in all patients undergoing ICSI, 
and the infection should be treated in positive patients prior 
to ICSI.
We also propose a large-scale study to be conducted on 
the effect of H. pylori infection on implantation and EPL in 
pregnancies conceived naturally, to further elucidate the role 
of H. pylori in pregnancy failure. Further studies are also 
required to elucidate the role of specific etiologic factors of 
infertility in EPL and related mechanisms.
Disclosure
The authors report no conflicts of interest in this work.
References
1.  Hajishafiha M, Zobairi T, Zanjani VR, Ghasemi-Rad M, Yekta Z, 
Mladkova N. Diagnostic value of sonohysterography in the determination 
of fallopian tube patency as an initial step of routine infertility   assessment. 
J Ultrasound Med. 2009;28(12):1671–1677.
2.  Templeton A. Infertility and the establishment of pregnancy – overview. 
Br Med Bull. 2000;56(3):577–587.
  3.  Smith S, Pfeifer SM, Collins JA. Diagnosis and management of female 
infertility. JAMA. 2003;290(13):1767–1770.
  4.  Cox GF, Burger J, Lip V, et al. Intracytoplasmic sperm injection 
may increase the risk of imprinting defects. Am J Hum Genet. 
2002;71(1):162–164.
  5.  Human Fertilisation and Embryology Authority, SAID. Latest UK 
IVF figures 2007 cited 2007; Available from: http://www.hfea.gov.uk/
ivf-figures-2006.html#1283. Accessed on September 13, 2011.
  6.  Van Steirteghem AC, Nagy Z, Joris H, Liu J, et al. High fertilization and 
implantation rates after intracytoplasmic sperm injection. Hum Reprod. 
1993;8(7):1061–1066.
  7.  Goker EN, Sendag F, Levi R, Sendag H, Tavmergen E. Comparison 
of the ICSI outcome of ejaculated sperm with normal, abnormal 
parameters and testicular sperm. Eur J Obstet Gynecol Reprod Biol. 
2002;104(2):129–136.
  8.  van Golde RJ, Wetzels AM, de Graaf R, Tuerlings JH, Braat DD, 
  Kremer JA. Decreased fertilization rate and embryo quality after 
ICSI in oligozoospermic men with microdeletions in the azoospermia 
factor c region of the Y chromosome. Hum Reprod. 2001;16(2): 
289–292.
  9.  Bahceci M, Ulug U. Does underlying infertility aetiology impact on 
first trimester miscarriage rate following ICSI? A preliminary report 
from 1244 singleton gestations. Hum Reprod. 2005;20(3):717–721.
  10.  Fedorcsak P, Storeng R, Dale PO, Tanbo T, Abyholm T. Obesity is 
a risk factor for early pregnancy loss after IVF or ICSI. Acta Obstet 
Gynecol Scand. 2000;79(1):43–48.
  11.  Hamlet A, Thoreson AC, Nilsson O, Svennerholm AM, Olbe L. 
Duodenal Helicobacter pylori infection differs in cagA genotype 
between asymptomatic subjects and patients with duodenal ulcers. 
Gastroenterology. 1999;116(2):259–268.
  12.  Redeen S, Petersson F, Tornkrantz E, Levander H, Mardh E, 
Borch K. Reliability of diagnostic tests for Helicobacter pylori   infection. 
  Gastroenterol Res Pract. 2011;2011:940650.
  13.  Figura N, Piomboni P, Ponzetto A, et al. Helicobacter pylori infection 
and infertility. Eur J Gastroenterol Hepatol. 2002;14(6):663–669.
  14.  Collodel G, Moretti E, Campagna MS, Capitani S, Lenzi C, Figura 
N. Infection by CagA-positive Helicobacter pylori strains may con-
tribute to alter the sperm quality of men with fertility disorders and 
increase the systemic levels of TNF-alpha. Dig Dis Sci. 2010;55(1): 
94–100.
  15.  Rossi G, Romagnoli S, Lauretti L, et al. Helicobacter pylori infec-
tion negatively influences pregnancy outcome in a mouse model. 
Helicobacter. 2004;9(2):152–157.
  16.  Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY. 
Relationship between Helicobacter pylori iceA, cagA, and vacA 
status and clinical outcome: studies in four different countries. J Clin 
  Microbiol. 1999;37(7):2274–2279.
  17.  Graham DY, Yamaoka Y. H. pylori and cagA: relationships with gastric 
cancer, duodenal ulcer, and reflux esophagitis and its complications. 
Helicobacter. 1998;3(3):145–151.
  18.  Aittomaki K, Wennerholm UB, Bergh C, Selbing A, Hazekamp J, 
Nygren KG. Safety issues in assisted reproduction technology: should 
ICSI patients have genetic testing before treatment? A practical 
proposition to help patient information. Hum Reprod. 2004;19(3): 
472–476.
  19.  Sitas F, Forman D, Yarnell JW, et al. Helicobacter pylori infection rates 
in relation to age and social class in a population of Welsh men. Gut. 
1991;32(1):25–28.
  20.  Malaty HM, El–Kasabany A, Graham DY, et al. Age at acquisition of 
Helicobacter pylori infection: a follow-up study from infancy to adult-
hood. Lancet. 2002;359(9310):931–935.
  21.  Winter E, Wang J, Davies MJ, Norman R. Early pregnancy loss 
  following assisted reproductive technology treatment. Hum Reprod. 
2002;17(12):3220–3223.
  22.  Fedorcsak P, Dale PO, Storeng R, et al. Impact of overweight and 
underweight on assisted reproduction treatment. Hum Reprod. 
2004;19(11):2523–2528.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
334
Hajishafiha et alInternational Journal of Women’s Health
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-womens-health-journal
The International Journal of Women’s Health is an international, peer-
reviewed open-access journal publishing original research, reports, 
reviews and commentaries on all aspects of women’s healthcare includ-
ing gynecology, obstetrics, and breast cancer. Subject areas include: 
Chronic conditions (migraine headaches, arthritis, osteoporosis); 
Endocrine and autoimmune syndromes; Sexual and reproductive 
health; Psychological and psychosocial conditions. The manuscript 
management system is completely online and includes a very quick 
and fair peer-review system. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.
International Journal of Women’s Health 2011:3
  23.  Bahceci M, Ulug U, Sismanoglu A, Tosun S, Cengiz B. Early   pregnancy 
loss rates were different among singleton gestations conceived by 
ICSI using GnRH agonist and antagonist. J Assist Reprod Genet. 
2009;26(4):227–229.
  24.  Dufour C, Brisigotti M, Fabretti G, Luxardo P, Mori PG, Barabino A. 
Helicobacter pylori gastric infection and sideropenic refractory anemia. 
J Pediatr Gastroenterol Nutr. 1993;17(2):225–227.
  25.  Eslick GD, Yan P, Xia HH, Murray H, Spurrett B, Talley NJ. Foetal 
intrauterine growth restrictions with Helicobacter pylori infection. 
Aliment Pharmacol Ther. 2002;16(9):1677–1682.
  26.  Arslan E, Colakoglu M, Celik C, et al. Serum TNF-alpha, IL-6, 
lupus anticoagulant and anticardiolipin antibody in women with and 
without a past history of recurrent miscarriage. Arch Gynecol Obstet. 
2004;270(4):227–229.
  27.  Hart R. PCOS and infertility. Panminerva Med. 2008;50(4):305–314.
  28.  Jafarzadeh A, Rezayati MT, Nemati M. Specific serum immunoglobulin 
G to H. pylori and CagA in healthy children and adults (south-east of 
Iran). World J Gastroenterol. 2007;13(22):3117–3121.
  29.  Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. Altered states: 
involvement of phosphorylated CagA in the induction of host cellular 
growth changes by Helicobacter pylori. Proc Natl Acad Sci U S A. 
1999;96(25):14559–14564.
  30.  Guiraldes E, Duarte I, Pena A, et al. Proinflammatory cytokine expres-
sion in gastric tissue from children with Helicobacter pylori-associated 
gastritis. J Pediatr Gastroenterol Nutr. 2001;33(2):127–132.
  31.  Heimonen A, Janket SJ, Meurman JH, Furuholm J, Ackerson LK, 
Kaaja R. Oral health care patterns and the history of miscarriage. Oral 
Dis. 2008;14(8):734–740.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
335
Effect of Helicobacter pylori on pregnancy rates